Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:BIOL OTCMKTS:REMI On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBIOLBIOLASE$0.01-1.0%$0.01$0.02▼$1.94$329K0.672.58 million shs248,762 shsREMIRemedent$0.01-10.0%$0.02$0.01▼$0.07N/A-0.1974,594 shs110,000 shs7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBIOLBIOLASE0.00%-5.10%-8.70%-28.03%-87.98%REMIRemedent-10.00%-10.00%-10.00%-66.54%-83.64%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationBIOLBIOLASE0.9863 of 5 stars3.50.00.00.00.60.00.0REMIRemedentN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBIOLBIOLASE 3.00Buy$1.2012,070.39% UpsideREMIRemedent 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBIOLBIOLASE$48.83M0.01N/AN/A($0.07) per share-0.14REMIRemedent$990KN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBIOLBIOLASE-$20.63M-$14.94N/A∞N/A-41.65%-1,782.73%-55.31%8/6/2025 (Estimated)REMIRemedent-$270K-$0.01N/A∞N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBIOLBIOLASEN/AN/AN/AN/AN/AREMIRemedentN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBIOLBIOLASEN/A0.710.36REMIRemedentN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBIOLBIOLASE8.79%REMIRemedentN/AInsider OwnershipCompanyInsider OwnershipBIOLBIOLASE0.27%REMIRemedentN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBIOLBIOLASE16033.41 million33.32 millionNot OptionableREMIRemedent4N/AN/ANot OptionableBIOL and REMI HeadlinesRecent News About These CompaniesReviewing Remedent (REMI) & Its CompetitorsJuly 14 at 2:58 AM | americanbankingnews.comFinancial Analysis: Remedent (REMI) vs. Its PeersJuly 8, 2025 | americanbankingnews.comRemedent (REMI) and Its Peers Head to Head AnalysisJuly 6, 2025 | americanbankingnews.comEx-Chelsea striker looks like completely new person just one year after retirementAugust 28, 2024 | mirror.co.ukMTikTok star Remi Bader shares fitness transformation after slamming trolls over weight criticismMay 25, 2024 | pagesix.comPRemi Bader Shows Off Body Transformation After 'Putting Myself First': 'This Is Not About Weight or Looks'May 25, 2024 | people.comPRémi Laurent Biography & MoviesApril 29, 2024 | tribute.caTRémi Laurent Biography & MoviesApril 29, 2024 | tribute.caTREMYY Rémy Cointreau SAApril 24, 2024 | seekingalpha.comRemi LambertFebruary 29, 2024 | thesun.co.ukPeterson RemyFebruary 15, 2024 | health.usnews.comRemi MonaghanJanuary 10, 2024 | fox17online.comFremy ma and papooseDecember 6, 2023 | hiphopwired.comHRémi Bonnet Breaks Longtime Pikes Peak Ascent RecordSeptember 25, 2023 | runnersworld.comRHome and Away spoiler: Remi keeps quiet about the kissAugust 20, 2023 | digitalspy.comDRemi Wolf Returns with New Single “Prescription,” Inspired by Phone Call with Boots Riley: StreamJune 2, 2023 | yahoo.comHome and Away spoilers: Remi collapses in Salt as his injury worsensMarch 27, 2023 | metro.co.ukMLove Island star Remi Lambert claims he was assaulted by one of Jacques O'Neill's friendsMarch 22, 2023 | mirror.co.ukMRemi Matthews focuses on the present with St JohnstoneMarch 17, 2023 | irishnews.comILioness of Bourdillon: How Remi Tinubu Becomes the New Beautiful BrideMarch 7, 2023 | thisdaylive.comTNew MarketBeat Followers Over TimeMedia Sentiment Over TimeBIOL and REMI Company DescriptionsBIOLASE NASDAQ:BIOL$0.0099 0.00 (-1.00%) As of 07/11/2025BIOLASE, Inc., together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications. The company offers Waterlase all-tissue dental laser systems for cutting soft and hard tissues; diode soft-tissue laser systems for soft tissue, hygiene, temporary pain relief, teeth whitening, and cosmetic procedures; and Epic Hygiene laser to manage non-surgical periodontitis and enhance clinical production. It also manufactures and sells consumable products and accessories for its laser systems, as well as markets flexible fibers and hand pieces; and sells teeth whitening gel kits. The company sells its products through its field sales force and distributor network. The company was formerly known as BIOLASE Technology, Inc. and changed its name to BIOLASE, Inc. in 2012. BIOLASE, Inc. was founded in 1984 and is headquartered in Foothill Ranch, California.Remedent OTCMKTS:REMI$0.0090 0.00 (-10.00%) As of 07/14/2025 03:55 PM EasternRemedent, Inc. researches, designs, develops, manufactures, and distributes oral care and cosmetic dentistry products in the United States and internationally. It primarily provides professional veneers and teeth whitening products for professional and over-the-counter use. The company also offers River8, a prefab veneer that enables the dentist to find the right combination of teeth for a patient with minor reshaping. In addition, it provides GlamSmile veneers, which are ultra-thin claddings attached to the front of the patient's teeth. Further, the company offers SmileMe Mirror, an integrated marketing concept for the dental practice that enables dentists to offer smile consultation in approximately 10 minutes; SmileSketch, a simulation software to make a sketch of what the patient could look like; and various Treatment Pages to explain the benefits of certain treatments, as well as Condor, an intra-oral 3D scanner. Additionally, it provides dental implant solutions and treatment concepts. The company sells its products through internal sales force and third party distributors. Remedent, Inc. was incorporated in 1986 and is headquartered in Ghent, Belgium. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Insider Selling Hits Market Leaders—Should You Be Worried? MP Materials Stock Booms on New Government Positioning Tilray Shares Blazing: What's Behind the 55% Rally This Month? MarketBeat Week in Review – 07/07 - 07/11 How Texas Roadhouse Is Winning in a Changing Consumer Market Power Solutions International Poised for 75% Upside The Meteoric Rise of Rocket Lab: A Space Stock to Watch Meta and Autonomous Advertising: The Stock's Next Big Tailwind? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
